Medical Devices and IVDs April 28, 2026

How Long Does FDA Medical Device Approval Take? (510(k), De Novo, PMA Timelines Explained)

OMC Admin

OMC AdminContent Writer

How Long Does FDA Medical Device Approval Take? (510(k), De Novo, PMA Timelines Explained)

One of the most common questions medical device manufacturers ask is:

πŸ‘‰ β€œHow long does FDA approval take?”

The answer depends on several factors, including your device classification, regulatory pathway, and submission quality.

Understanding approval timelines is critical for: Product launch planning Budget allocation Market entry strategy

Ready to Streamline Your Regulatory Compliance?

Join hundreds of companies who trust OMC Medical for their regulatory needs. Get expert guidance and ensure compliance across all markets.

Call Now +44 208 066 7260

In this guide, we break down FDA medical device approval timelines for: --> 510(k) --> De Novo --> PMA

…and explain how to avoid delays and speed up your approval process.

Overview of FDA Approval Pathways

Before diving into timelines, it’s important to understand the three main FDA pathways:

1. 510(k) Submission

Used for devices that demonstrate substantial equivalence to an existing device.

πŸ‘‰ Refer to the 510(k) submission process for detailed requirements.

2. De Novo Pathway

Used for novel, low-to-moderate risk devices without a predicate.

3. Premarket Approval (PMA)

Required for high-risk devices with the most stringent requirements.

πŸ‘‰ Each pathway has very different timelines and complexity levels.

510(k) Approval Timeline

Average Timeline: 3 to 6 Months

The 510(k) pathway is the fastest and most common route.

FDA Review Timeline

FDA review goal: ~90 days Total timeline (including preparation): 3–6 months

Typical Process

Preparation of submission (4–8 weeks) FDA acceptance review (15 days) Substantive review (60 days) Additional Information (if required) Final decision

What Can Delay 510(k)?

Poor predicate selection --> Incomplete documentation --> Additional Information (AI) requests --> Weak performance data

De Novo Approval Timeline

Average Timeline: 6 to 12 Months

The De Novo pathway is used when no predicate device exists.

FDA Review Timeline FDA goal: ~150 days Total timeline: 6–12 months

Typical Process

1. Pre-submission interaction (optional but recommended) 2. Submission preparation 3. FDA review 4. Requests for additional data 5. Final classification decision

Common Delays

--> Insufficient clinical evidence --> Unclear risk classification --> Novel technology challenges

πŸ‘‰ De Novo requires more data than 510(k), but less than PMA.

PMA Approval Timeline

Average Timeline: 1 to 3 Years

PMA is the most rigorous pathway for high-risk devices.

FDA Review Timeline

FDA goal: ~180 days (review only) Total timeline: 1–3 years (including clinical trials)

Typical Process

1. Clinical trial planning 2. Conducting clinical studies (6 months to 2+ years) 3. Submission preparation 4. FDA scientific review 5. Advisory panel review (if required) 6. Approval decision

Why PMA Takes Longer --> Requires clinical trial data --> Extensive safety and effectiveness evaluation --> Complex review process

πŸ‘‰ This pathway is typically used for Class III devices.

Comparison of FDA Approval Timelines

Pathway

Risk Level

Average Timeline

510(k)

Low–Moderate

3–6 months

De Novo

Moderate

6–12 months

PMA

High

1–3 years

πŸ‘‰ Choosing the right pathway is critical for timeline optimization.

Factors That Affect FDA Approval Time

Approval timelines are not fixedβ€”they depend on several variables:

1. Device Classification

Higher risk = longer approval timeline

πŸ‘‰ Learn more in your FDA Medical Device Classification: Class I, II, III Explained blog.

2. Quality of Submission

Incomplete or unclear submissions lead to: --> Additional Information requests --> Review delays

3. Clinical Data Requirements

No clinical data β†’ faster approval Clinical trials β†’ longer timelines

4. Predicate Device Selection

For 510(k), a strong predicate: --> Simplifies review --> Reduces FDA queries

5. FDA Workload

Review timelines may vary depending on: --> Submission volume --> Regulatory priorities

Common Reasons for FDA Delays

Avoid these common pitfalls:

❌ Incomplete Documentation

Missing required sections or data

❌ Poor Regulatory Strategy

Choosing the wrong pathway

❌ Weak Clinical Evidence

Insufficient data to support claims

❌ Ignoring FDA Guidelines

Non-compliance with requirements

πŸ‘‰ These issues often lead to delays or rejection.

How to Speed Up FDA Approval

βœ” Start with the Right Strategy

Correct classification and pathway selection

βœ” Conduct Pre-Submission Meetings

Get FDA feedback early

βœ” Prepare High-Quality Documentation

Ensure completeness and accuracy

βœ” Choose Strong Predicate Devices

Simplify 510(k) approval

βœ” Ensure Compliance with Current Good Manufacturing Practices (CGMP)

Avoid inspection-related delays

πŸ‘‰ A proactive approach significantly reduces approval time.

How OMC Medical Can Help

FDA approval timelines depend heavily on expertise and preparation.

OMC Medical provides: --> Regulatory pathway strategy --> 510(k), De Novo, and PMA support --> Predicate device selection --> Clinical strategy guidance --> Documentation and submission support --> FDA compliance and inspection readiness

πŸ‘‰ We help you reduce approval timelines and avoid costly delays.

Conclusion

FDA approval timelines vary depending on the pathway: --> 510(k) β†’ Fastest (3–6 months) --> De Novo β†’ Moderate (6–12 months) --> PMA β†’ Longest (1–3 years)

However, timelines can be significantly impacted by: --> Submission quality --> Regulatory strategy --> Clinical data requirements

With the right approach and expert support, you can: --> Accelerate approval --> Reduce risk --> Enter the US market faster

FAQs

Q1. What is the fastest FDA approval pathway?
510(k) is typically the fastest pathway.

Q2. How long does a 510(k) take?
Usually 3–6 months, depending on submission quality.

Q3. Why does PMA take so long?
Because it requires clinical trials and extensive review.

Q4. Can FDA approval be expedited?
Yes, with proper strategy, pre-submissions, and expert support.

Enjoyed this article?

Share it with your network and help others discover great content.

Related Blogs

Stay updated with the latest regulatory updates and insights

How Regulatory Harmonization Could Speed Up Medical Device Approvals by 2026

November 13, 2025

How Regulatory Harmonization Could Speed Up Medical Device Approvals by 2026
Learn More
MDCG Guidance for Manufacturers of Class I Medical Devices

October 15, 2025

MDCG Guidance for Manufacturers of Class I Medical Devices
Learn More
How to Register Medical Devices in the Saudi Market?

October 16, 2025

How to Register Medical Devices in the Saudi Market?
Learn More
LinkedIn Message on LinkedIn WhatsApp Start WhatsApp chat Call Call us